Switching from Mounjaro to compounded tirzepatide: what the evidence says

What did @charlotte_mj36 actually say?

Straightforwardly: nothing medically specific. The transcript is entirely song lyrics. There are no spoken claims about tirzepatide, dosing, weight loss mechanisms, or compounded peptides in the audio itself. All the factual content comes from the caption, where Charlotte states she lost 11 lbs after switching from Mounjaro to what she calls "T-compound," starting at 2.5mg for four weeks before moving to 5mg, and credits the account @peptigen.

That means we are fact-checking a caption, not a verbal medical claim. That matters because captions are easy to type without thinking through the implications. What's here is a personal testimonial with specific dosing detail, a product tag, and a weight result. Those three things together carry real-world influence even at 1.8K views, and they deserve scrutiny.

Does the science back this up?

The weight loss trajectory described is plausible, though it cannot be verified from a caption alone. What is verifiable is the broader clinical picture around tirzepatide.

Tirzepatide is a dual GIP and GLP-1 receptor agonist. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) found that participants on 5mg tirzepatide lost an average of 15% of body weight over 72 weeks compared to 3.1% on placebo. Early weight loss in the first four to eight weeks on lower doses tends to be modest. An 11-lb loss across an unspecified timeline could fit within that range for some patients, but we have no baseline weight, no timeline beyond dose titration weeks, and no clinical context.

The step-up from 2.5mg to 5mg described follows the standard tirzepatide titration schedule used in Zepbound and Mounjaro labeling, which starts at 2.5mg for four weeks before escalating. So the dosing pattern mentioned is consistent with how the drug is clinically managed.

What did they get wrong, or right?

Charlotte did not make explicit false claims about how tirzepatide works, which is actually more than you can say for a lot of GLP-1 content on TikTok. She did not claim it cures diabetes, did not describe it as without side effects, and did not tell viewers to take a specific dose. That is worth acknowledging.

Where things get complicated is the implied equivalency between Mounjaro and "T-compound." Compounded tirzepatide is not the same as FDA-approved Mounjaro or Zepbound. Compounded versions are not evaluated by the FDA for safety, efficacy, or manufacturing consistency. The FDA removed tirzepatide from its drug shortage list in 2024, which means compounding it outside of specific patient-need exemptions sits in contested regulatory territory. Tagging a commercial supplier in a weight loss post nudges this into endorsement territory without any disclosure of whether this is a paid partnership, which would be required under FTC guidelines.

What should you actually know?

If you are considering a switch from a branded GLP-1 to a compounded version, the decision is more complicated than a caption makes it look. Compounded tirzepatide may contain the same active molecule, but the salt form, excipients, and manufacturing standards vary between compounding pharmacies. There is currently no published head-to-head trial comparing compounded tirzepatide to Zepbound or Mounjaro in terms of absorption, tolerability, or outcomes.

The 2.5mg to 5mg titration Charlotte describes is consistent with standard prescribing practice, but that does not mean it is appropriate for every person. Titration decisions should be made with a licensed prescriber who has access to your full medical history. A TikTok caption is not a titration plan.

Weight loss results from GLP-1 medications also depend heavily on adherence, dietary patterns, and individual metabolic response. Eleven pounds is a real result for one person. It tells you nothing about what you would lose.